Tech Company Financing Transactions
Platelet Biogenesis Funding Round
On 6/21/2019, Platelet Biogenesis raised $11.4 million in investment from private investors.
Transaction Overview
Company Name
Announced On
6/21/2019
Transaction Type
Venture Equity
Amount
$11,364,976
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 33 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
325 Vassar St. 2A
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Platelet BioGenesis is a Harvard University spinout that is making human platelets from stem cells. We have developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human pluripotent stem cell cultures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sam Rasty
Chief Operating Officer
Sven Karlsson
Chief Scientific Officer
Jonathan Thon
Browse more venture capital transactions:
Prev: 6/21/2019: Druva venture capital transaction
Next: 6/21/2019: Engage3 venture capital transaction
Share this article
News on VC Transactions
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs